Xilio Therapeutics is a biotechnology company that discovers and develops immuno-oncology therapeutics for the treatment of lung cancer. Xilio Therapeutics is headquartered in Waltham, Massachusetts, ...

Vilastobart is under clinical development by Xilio Therapeutics and currently in Phase II for Metastatic Colorectal Cancer.